The drug ACNETTOCIN contains one active pharmaceutical ingredient (API):
Clindamycin is a lincosamide antibiotic with a primarily bacteriostatic action against Gram-positive aerobes and a wide range of anaerobic bacteria. Lincosamides such as clindamycin bind to the 50S subunit of the bacterial ribosome and inhibit the early stages of protein synthesis.
This brand name is authorized in the following countries: Hong Kong
This drug has been assigned below unique identifiers within the countries it is being marketed: